Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall neurontinPfizer Corporation has been under investigation for illegally marketing the epilepsy drug Neurontin. According to FDA approval, Neurontin was intended as an add-on epilepsy treatment. Soon after, though, off-label use became a regular, widespread practice. Neurontin soon became a runaway success with sales over $1 billion per year through a grand marketing scheme by Pfizer Corporation in which doctors received kickbacks for prescribing Neurontin for off-label uses. The majority of sales were estimated to have come from off-label use, not the original intended use of epilepsy treatment.
Neurontin attorneys continue to oppose Neurontin''s presence on the market, calling it the most complete and well documented case of off-label promotion ever exposed. Pfizer is currently the target of Neurontin related lawsuits. The side effects of Neurontin have caused serious medical complications in some patients and have most recently been linked to suicide and attempted suicides.
Neurontin has turned into the late-20th century version of snake oil. Neurontin attorneys have found that the drug has been illegally promoted for the treatment of the following disorders: bipolar disorder, pain syndromes, peripheral neuropathy, and diabetic neuropathy, treatment of epilepsy alone as mono-therapy, reflex sympathetic dystrophy, attention deficit disorder, restless leg syndrome, trigeminal neuralgia, post-hepatic neuralgia, essential tremor periodic limb movement, migraines, drug and alcohol withdrawal, seizures, Lou Gherig’s disease, and several conditions associated with chronic pain.
The side effects of Neurontin vary between adults and children. Adults taking Neurontin can experience dizziness, sleepiness, vision problems, swelling of hands or feet, diarrhea, clumsiness, weakness, and most of all suicidal behavior. Children usually take Neurontin to control partial seizures. It has also been indicated that children are more susceptible to Neurontin side effects compared to adults, and that children taking this medication are far more likely to experience the behavioral Neurontin side effects, as well as fever, nausea, vomiting, viral infection, mood swings, hyperactivity, aggression and lack of concentration. If your child experienced any of these symptoms you should contact a Neurontin attorney.
There are clearly patients for whom Neurontin, initially, is a miracle drug. It seems to double as an antidepressant and an anti-anxiety medication, but over the course of time, for almost all patients those benefits are lost. After the first year of using the medication no patients were still doing well on Neurontin alone as a monotherapy.
The main study, sponsored by Pfizer, showed Neurontin less effective than a placebo, and of course, the results were not published for quite a while. A second randomized trial performed by The National Institute of Mental Health found no difference between Neurontin and placebo. The fact that the manufacturer has chosen not to pursue any more studies of Neurontin as a mood stabilizer proves its ineffectiveness.
However, Neurontin clearly helps some people and the results can be dramatic. Some patients said that after 15 minutes following the first dose, their joy receptors turned back on. Unfortunately, within 6 months it was apparent that Neurontin was causing the same rapid cycling that they had experienced on other antidepressants.
Side effects other than those listed here may also occur. Talk to your doctor about any unusual side effects from Neurontin. If you are diagnosed with any serious conditions that may be linked to your long-term use of Neurontin, or if you have been prescribed Neurontin for off-label uses, contact a Neurontin attorney for immediate legal assistance. You could potentially have a claim for a lawsuit, but only a qualified and experienced Neurontin attorney can tell.
The FDA has requested 14 drugmakers to check their study data to see if use of epilepsy drugs results in suicidal behavior or thoughts, giving the drugmakers six months to respond.
Sales of anti-seizure drugs in the U.S. during 2004 were th...
Just weeks after Pfizer and its Warner-Lambert Co. unit were penalized $430 million in federal and state courts for selling Neurontin for purposes that have not yet been FDA approved, the company is again under fire for fraudulent marketing practices. ...
The world''s largest drug manufacturer, Pfizer, Inc., agreed to pay at least $400 million in order to settle civil charges regarding kickbacks to encourage doctors to prescribe the anti-epileptic drug Neurontin for other purposes.
The se...